Clinical trial
Glycan Near-Infrared Imaging Using Fluorescently Labeled Wheat Germ Agglutinin (WGA): Evaluation of Safety and Feasibility in a Prospective Pilot Study
NCT07643727 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycan Near-Infrared Imaging Using Fluorescently Labeled Wheat Germ Agglutinin (WGA): Evaluation of Safety and Feasibility in a Prospective Pilot Study
- Lead sponsor
- University Medical Center Groningen
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- October 31, 2028
- Enrollment
- 49 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
barrett esophagus adenocarcinoma, barrett's esophagus with or without dysplasia